Ziopharm Oncology reported $76.75M in Cash and Equivalent for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Amgen AMGN:US $ 6630M 518M
Arena Pharmaceuticals ARNA:US $ 514.18M 81.2M
AstraZeneca AZN:LN 15567M 7931M
Baxter International BAX:US $ 3136M 46M
Biogen BIIB:US $ 1742M 524.5M
Bristol Myers Squibb BMY:US $ 11024M 42M
Corcept Therapeutics CORT:US $ 95.43M 43.05M
Curis CRIS:US $ 75.03M 36.01M
Eleven Biotherapeutics EBIO:US $ 151.04M 41.07M
Gilead Sciences GILD:US $ 7361M 3296M
GlaxoSmithKline GSK:LN 3503M 1254M
Immunogen IMGN:US $ 239.54M 43.58M
Intercept Pharmaceuticals ICPT:US $ 145.62M 52.67M
Intrexon XON:US $ 36.41M 9.06M
IONIS PHARMACEUT IONS:US $ 565.12M 150.96M
Karyopharm Therapeutics KPTI:US $ 141.31M 52.84M
Novartis NOVN:VX SF 5117M 1316M
Ptc Therapeutics PTCT:US $ 177.35M 30.72M
Regeneron Pharmaceuticals REGN:US $ 2072.2M 634.3M
Sangamo Biosciences SGMO:US $ 169.88M 46.9M
Tg Therapeutics TGTX:US $ 456.22M 15.3M
Verastem VSTM:US $ 24.97M 10.54M
YTE INCY:US $ 1797.58M 127.61M
Ziopharm Oncology ZIOP:US $ 76.75M 23.31M